|1.||Iseki, Hiroshi: 3 articles (05/2013 - 01/2008)|
|2.||Muragaki, Yoshihiro: 3 articles (05/2013 - 01/2008)|
|3.||Liao, Hongen: 3 articles (05/2013 - 01/2008)|
|4.||Sakuma, Ichiro: 3 articles (05/2013 - 01/2008)|
|5.||Maruyama, Takashi: 3 articles (05/2013 - 01/2008)|
|6.||Kobayashi, Etsuko: 3 articles (05/2013 - 01/2008)|
|7.||Noguchi, Masafumi: 2 articles (04/2012 - 01/2008)|
|8.||Maluf, Fernando V: 1 article (02/2015)|
|9.||Bueno, Vânia B: 1 article (02/2015)|
|10.||Matias, Tiago A: 1 article (02/2015)|
|1.||Neurologic Manifestations (Neurological Manifestations)
03/15/2008 - "Effect of serum and BSA on the cytotoxicity of metal protoporphyrins in glioma cells is first demonstrated in the present study, and the roles of ROS, MAPKs, and HO-1 were elucidated."
08/01/2012 - "5-aminolevulinic acid (5-ALA) is a pro-drug that leads to accumulation of fluorescent protoporphyrins in malignant gliomas. "
04/01/2012 - "5-ALA is a non-fluorescent prodrug that leads to intracellular accumulation of fluorescent protoporphyrins IX (PpIX) in malignant glioma. "
01/01/2008 - "5-ALA is a non-fluorescent prodrug that leads to intracellular accumulation of fluorescent protoporphyrins IX (PpIX) in malignant glioma. "
01/01/1990 - "Erythropoietic protoporphyria (EPP) is characterized by increased red cell protoporphyrins and is included in the differential diagnosis of children presenting with photosensitivity. "
08/01/1995 - "Erythropoietic protoporphyria is an inherited disorder of porphyrin metabolism, in which reduced activity of the enzyme ferrochelatase leads to accumulation of protoporphyrins in erythrocytes. "
08/01/1977 - "Comparative study of protoporphyrins in erythropoietic protoporphyria and griseofulvin-induced murine protoporphyria. "
08/01/1977 - "Excess erythrocyte protoporphyrins of human congenital erythropoietic protoporphyria and of griseofulvin-induced murine hepatic protoporphyria were found to be associated with hemoglobin and stroma fractions in similar relationships. "
03/27/2002 - "Erythropoietic protoporphyria (EPP) is a rare inherited disorder of the heme biosynthetic pathway in which toxic levels of protoporphyrins often precipitate in the liver, leading to cirrhosis, liver failure, and the need for liver transplantation (OLT). "
06/16/1983 - "In porphyria variegata, fecal protoporphyrins are significantly increased. "
07/01/1986 - "Examination of stools demonstrated an increase of protoporphyrins and coproporphyrins, with prevalence of the former, characteristic of porphyria variegata. "
03/14/2014 - "Although loss of MFRN1 in zebrafish and mice leads to profound anemia, mutant animals showed no overt signs of porphyria, suggesting that mitochondrial iron deficiency does not result in an accumulation of protoporphyrins. "
11/01/1987 - "Biochemically elevated levels of protoporphyrins in erythrocytes, uroporphyrins in urine, and coproporphyrins in feces are markers of this form of porphyria. "
06/01/2007 - "Porphyrinogenic drugs, such as griseofulvin, cause mechanism-based heme inactivation, leading to formation of ferrochelatase-inhibitory N-alkylated protoporphyrins and resulting in porphyria. "
09/01/1988 - "Content of copro- and protoporphyrins was studied in erythrocytes of women with tumor of genitals. "
05/01/2013 - "A 5-aminolevulinic acid-induced fluorescent protoporphyrins IX (PpIX)-based intra-operative fluorescence measurement and corresponding spectra analysis technique is used to identify the position of tumors. "
12/01/1986 - "Elevation of erythrocyte zinc- and free protoporphyrins with metastatic spread in cancer patients."
05/05/2006 - "Furthermore, protoporphyrins are essential, in the form of heme, for the synthesis of nitric oxide, over-production of which is associated with cancer. "
|9.||Reactive Oxygen Species (Oxygen Radicals)